Login / Signup

Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country.

Jayastu SenapatiRishi DhawanMukul AggarwalPradeep KumarGanesh Kumar VishwanathanJasmita DassSeema TyagiManoranjan MahapatraTulika Seth
Published in: Leukemia & lymphoma (2021)
Keyphrases
  • combination therapy
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • chronic lymphocytic leukemia
  • middle aged
  • acute lymphoblastic leukemia